Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse.

PubWeight™: 2.15‹?› | Rank: Top 2%

🔗 View Article (PMID 333124)

Published in J Natl Cancer Inst on November 01, 1977

Authors

S Green, A Dobrjansky, M A Chiasson, E Carswell, M K Schwartz, L J Old

Articles citing this

Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. Proc Natl Acad Sci U S A (1983) 3.83

Possible importance of macrophage-derived mediators in acute malaria. Infect Immun (1981) 3.58

Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res (1985) 3.09

Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant. Infect Immun (1985) 2.04

High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors. J Exp Med (1985) 2.00

The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunity. J Exp Med (1978) 1.96

The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J Exp Med (1988) 1.77

A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity. Proc Natl Acad Sci U S A (1987) 1.54

The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity. J Exp Med (1978) 1.43

Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor. Proc Natl Acad Sci U S A (1986) 1.28

The antitumor function of tumor necrosis factor (TNF) II. Analysis of the role of endogenous TNF in endotoxin-induced hemorrhagic necrosis and regression of an established sarcoma. J Exp Med (1988) 1.27

Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect Immun (1992) 1.20

High-level induction of gamma interferon with various mitogens in mice pretreated with Propionibacterium acnes. Infect Immun (1982) 1.14

Enhancement of lipopolysaccharide-induced tumor necrosis factor production in mice by carrageenan pretreatment. Infect Immun (1991) 1.03

The use of lipoteichoic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumour necrosis. Br J Cancer (1985) 1.02

Use of immune modulators in nonspecific therapy of bacterial infections. Antimicrob Agents Chemother (1992) 0.93

Selective enhancement of the tumour necrotic activity of TNF alpha with monoclonal antibody. Br J Cancer (1992) 0.89

Differential effects of small tumour necrosis factor-alpha peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activity. Immunology (1993) 0.88

Induction of macrophage-mediated production of tumor necrosis factor alpha by an L-form derived from Staphylococcus aureus. Infect Immun (1993) 0.84

Adjuvant effect of killed Propionibacterium acnes on mouse peritoneal B-1 lymphocytes and their early phagocyte differentiation. PLoS One (2012) 0.83

Macrophage functions in Biozzi mice. Immunology (1985) 0.83

Production of lymphocyte activating factor in vivo. Immunology (1983) 0.82

Modulation of Th1/Th2 immune responses by killed Propionibacterium acnes and its soluble polysaccharide fraction in a type I hypersensitivity murine model: induction of different activation status of antigen-presenting cells. J Immunol Res (2015) 0.80

Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicin. Proc Natl Acad Sci U S A (1988) 0.79

Immunological priming attenuates the in vivo pathophysiological response to lipopolysaccharide. Comparison of cytokine production, tissue injury, and lethality in complete Freund's adjuvant-primed mice and in unprimed mice. Am J Pathol (1994) 0.77

Articles by these authors

An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 23.42

A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc Natl Acad Sci U S A (1977) 13.96

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (1990) 11.92

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44

Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (1986) 11.35

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature (2001) 11.03

Tumor necrosis factor (TNF). Science (1985) 8.80

Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse. Proc R Soc Lond B Biol Sci (1968) 7.51

Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells. J Exp Med (1975) 7.20

Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci U S A (1979) 6.93

Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A (1976) 6.82

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A (1998) 6.82

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A (1997) 6.67

Functional domains of the human estrogen receptor. Cell (1987) 6.52

Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses. J Exp Med (1966) 6.45

Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J (1986) 6.08

The G (Gross) leukemia antigen. Cancer Res (1965) 6.07

The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome. J Exp Med (1971) 6.06

Nuclear receptors enhance our understanding of transcription regulation. Trends Genet (1988) 5.95

Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor. Nature (1987) 5.47

Surface alloantigens of plasma cells. J Exp Med (1970) 5.19

Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis (1997) 5.13

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med (1998) 5.06

Early clinical and laboratory indicators of acute dengue illness. J Infect Dis (1997) 5.00

Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA (1995) 4.88

Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci U S A (1980) 4.66

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med (1998) 4.65

Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro. J Exp Med (1968) 4.63

Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci U S A (1985) 4.58

Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice. Proc Natl Acad Sci U S A (1976) 4.52

The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J (1986) 4.47

The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator. Cell (1988) 4.22

The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell (1988) 4.17

Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera. Proc Natl Acad Sci U S A (1979) 4.14

Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A (1997) 4.10

Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med (1997) 4.00

Serological analysis of cell surface antigens of malignant human brain tumors. Proc Natl Acad Sci U S A (1978) 3.99

Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma. J Exp Med (1977) 3.93

The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene. EMBO J (1992) 3.92

Current enigmas in cancer research. Harvey Lect (1973) 3.91

Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. Proc Natl Acad Sci U S A (1983) 3.83

HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. Ann Intern Med (1993) 3.78

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes (1989) 3.74

p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. Proc Natl Acad Sci U S A (1981) 3.72

Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture. Cancer Res (1981) 3.62

Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells. Proc Natl Acad Sci U S A (1982) 3.58

Antigenic structure of cell surfaces. An immunoferritin study of the occurrence and topography of H-2' theta, and TL alloantigens on mouse cells. J Exp Med (1969) 3.53

Immunoglobulin and other surface antigens of cells of the immune system. J Exp Med (1971) 3.50

An approach to the mapping of antigens on the cell surface. Proc Natl Acad Sci U S A (1968) 3.46

Screening for prostate cancer. Cochrane Database Syst Rev (2006) 3.46

Substance use and high-risk sex among men who have sex with men: a national online study in the USA. AIDS Care (2004) 3.44

Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med (1979) 3.43

Antigens of tumors and leukemias induced by viruses. Fed Proc (1966) 3.43

Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics. J Exp Med (1977) 3.42

Genetic linkage relationships of loci specifying differentiation alloantigens in the mouse. Transplantation (1972) 3.34

Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med (1982) 3.27

Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody. Proc Natl Acad Sci U S A (1967) 3.26

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity (1994) 3.24

Isolation and some characteristics of a group-specific antigen of the murine leukemia viruses. Virology (1969) 3.21

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci U S A (2000) 3.00

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer (2001) 2.95

Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc Natl Acad Sci U S A (1986) 2.94

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci U S A (1990) 2.91

Mouse isoantigens: separation of soluble TL (thymus-leukemia) antigen from soluble H-2 histocompatibility antigen by column chromatography. J Exp Med (1967) 2.86

Shared viral antigen of mammalian leukaemia viruses. Nature (1970) 2.84

Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity (2000) 2.81

Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA (2000) 2.80

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci U S A (2000) 2.79

G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc Natl Acad Sci U S A (1970) 2.77

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J Exp Med (1982) 2.74

Immunogenetics of cell surface antigens of mouse leukemia. Annu Rev Genet (1977) 2.69

Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med (1978) 2.69

Genomic organization of the human oestrogen receptor gene. EMBO J (1988) 2.65

Use of hybrid antibody with anti-gamma-G and anti-ferritin specificities in locating cell surface antigens by electron microscopy. J Exp Med (1968) 2.62

Detection of antibody to autologous human leukemia cells by immune adherence assays. Proc Natl Acad Sci U S A (1977) 2.59

Occurrence of natural antibody to the G (gross) leukemia antigen in mice. Cancer Res (1966) 2.57

T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures. Proc Natl Acad Sci U S A (1984) 2.54

Thymus cells of radiation-chimeras: TL phenotype, sensitivity to guinea-pig serum, and origin from donor cells. Nature (1965) 2.54

Short course prednisolone for adhesive capsulitis (frozen shoulder or stiff painful shoulder): a randomised, double blind, placebo controlled trial. Ann Rheum Dis (2004) 2.54

Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens. J Exp Med (1981) 2.53

Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci U S A (1999) 2.53

Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2. J Exp Med (1973) 2.52

Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med (1995) 2.50

A new method of estimating prevalence of injecting drug use in an urban population: results from a Scottish city. Int J Epidemiol (1991) 2.49

The 40K activity of one gram of potassium. Phys Med Biol (1997) 2.48

Serologically demonstrable alloantigens of mouse epidermal cells. J Exp Med (1972) 2.48

Effect of tumour necrosis factor on cultured human melanoma cells. Nature (1975) 2.46

Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci U S A (1994) 2.44

Partial purification of a serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1976) 2.42

A superfamily of potentially oncogenic hormone receptors. Nature (1987) 2.40

Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem (1990) 2.37

Horizontal transmission of feline leukaemia virus. Nature (1973) 2.34

Women at a sexually transmitted disease clinic who reported same-sex contact: their HIV seroprevalence and risk behaviors. Am J Public Health (1995) 2.34

Group-specific viral antigens in the milk and tissues of mice naturally infected with mammary tumor virus or Gross leukemia virus. Virology (1968) 2.26